Metabolic liver disease is the underlying diagnosis in only a small proportion of patients who undergo liver transplantation (LT), but for these patients, LT is life-saving. Patients with metabolic liver disease often do not present with typical findings of end-stage liver dis-ease and require special consideration and scrutiny concerning the appropriateness and timing of LT. Liver-based metabolic disease is classified into 3 types: (1) disease that causes structural liver damage with liver failure or cirrhosis, (2) metabolic disease without struc-tural liver damage that affects other organs (especially the central nervous system), and (3) metabolic disease with systemic deficiencies that are partially represented in the liver. There may be...
In the last years, nonalcoholic steatohepatitis (NASH) has become a leading indication for liver tra...
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in many c...
Background: Recently, the term metabolic dysfunction-associated fatty liver disease (MAFLD) was prop...
Mitochondrial respiratory chain disease may lead to neonatal or late onset liver failure, requiring ...
The metabolic syndrome (MS), which includes obesity, dyslipidaemia, hypertension and hyperglycaemia ...
Mitochondrial respiratory chain disease may lead to neonatal or late onset liver failure, requiring ...
AbstractMetabolic diseases that involve the liver represent a heterogeneous group of disorders. Apar...
The prerequisite for liver transplantation as a therapeutic option for inherited metabolic diseases ...
Liver transplant is the unique curative therapy for patients with acute liver failure or end-stage l...
The prerequisite for liver transplantation as a therapeutic option for inherited metabolic diseases ...
Liver based metabolic disorders account for 10 to 15% of the indications for paediatric liver transp...
The increasing prevalence of diabetes mellitus, obesity, and metabolic syndrome in the population ca...
Abstract The clinical significance of liver disease is frequently underestimated in patients with m...
Nonalcoholic fatty liver disease (NAFLD) represents one of the most diffuse liver diseases worldwide...
Purpose: Metabolic liver disease (MLD) often progresses to life-threatening conditions. This study i...
In the last years, nonalcoholic steatohepatitis (NASH) has become a leading indication for liver tra...
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in many c...
Background: Recently, the term metabolic dysfunction-associated fatty liver disease (MAFLD) was prop...
Mitochondrial respiratory chain disease may lead to neonatal or late onset liver failure, requiring ...
The metabolic syndrome (MS), which includes obesity, dyslipidaemia, hypertension and hyperglycaemia ...
Mitochondrial respiratory chain disease may lead to neonatal or late onset liver failure, requiring ...
AbstractMetabolic diseases that involve the liver represent a heterogeneous group of disorders. Apar...
The prerequisite for liver transplantation as a therapeutic option for inherited metabolic diseases ...
Liver transplant is the unique curative therapy for patients with acute liver failure or end-stage l...
The prerequisite for liver transplantation as a therapeutic option for inherited metabolic diseases ...
Liver based metabolic disorders account for 10 to 15% of the indications for paediatric liver transp...
The increasing prevalence of diabetes mellitus, obesity, and metabolic syndrome in the population ca...
Abstract The clinical significance of liver disease is frequently underestimated in patients with m...
Nonalcoholic fatty liver disease (NAFLD) represents one of the most diffuse liver diseases worldwide...
Purpose: Metabolic liver disease (MLD) often progresses to life-threatening conditions. This study i...
In the last years, nonalcoholic steatohepatitis (NASH) has become a leading indication for liver tra...
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in many c...
Background: Recently, the term metabolic dysfunction-associated fatty liver disease (MAFLD) was prop...